BCMA-Targeted, Hypoimmune Allogeneic CAR T Cells Exhibit Potent Anti-Tumor Activity Together with the Ability to Evade Innate and Adaptive Immune Rejection in Pre-Clinical Tumor Models
Jeremy M. Kinder(Sana Biotechnology (United States)), Aaron E. Foster(Medpace (United States)), Chanel Athena-Estrada(Sana Biotechnology (United States)), Danyal Malik(Sana Biotechnology (United States)), Terry J. Fry(University of Colorado Anschutz Medical Campus), Neal Van Hoeven(Sana Biotechnology (United States)), Jesus Moreno(Sana Biotechnology (United States)), Garrett Zipp(Sana Biotechnology (United States)), Sonja Schrepfer(Cedars-Sinai Medical Center), Chi Young(Sana Biotechnology (United States)), Ouwen Liang(Sana Biotechnology (United States)), Aaron Lampano(Fred Hutch Cancer Center), Brian Granger(Sana Biotechnology (United States)), Xiaomeng Hu(Huzhou University), Adam Johnson(Sana Biotechnology (United States)), Vandana Chaturvedi(Sana Biotechnology (United States)), Meghan Lamba(Sana Biotechnology (United States))
Cited by 1
Related Papers
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air
|Proceedings of the National Academy of Sciences|2009|224
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility
|Proceedings of the National Academy of Sciences|2008|198
The <i>Mx1</i> Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses
|Journal of Virology|2007|182